Key result
Being underweight is linked to ~83% greater postoperative mortality after hepatocellular carcinoma surgery.
Why the study?
Does being underweight increase the rate of postoperative death in patients undergoing surgery for HCC?
Cohort (n=342)
Does being underweight increase the rate of postoperative death in patients undergoing surgery for HCC?
Being underweight (BMI < 22.5) is an independent predictor of increased postoperative mortality in patients undergoing surgery for hepatocellular carcinoma.
Underweight HCC patients may warrant closer perioperative monitoring; this observational association leaves open whether nutritional optimization improves survival.
OBJECTIVE: To evaluate the influence of body mass index (BMI) on postoperative death in patients undergoing surgery for HCC. METHODS: Three hundred forty-two patients were enrolled, and divided into three groups: Group A, BMI <22.5; Group B, BMI ≥22.5 to <25; Group C, BMI ≥25. Univariate and multivariate analyses of postoperative death were performed to compare BMI with clinical factors. Kaplan-Meier analysis and log rank test were used to compare such outcome in Groups A, B, and C. RESULTS: Kaplan-Meier analysis and log rank test revealed that Group A had a higher rate of postoperative death than Group B or C (P = 0.010). Univariate and multivariate analyses selected being underweight (Group B, C/Group A) (odds ratio, 1.829; 95% C.I., 1.091-3.068; P = 0.022) as one of the factors predictive of postoperative death, together with aspartate aminotransferase level (P = 0.042) and HCC growth pattern (P = 0.032). CONCLUSIONS: BMI is a simple but important predictor of postoperative death in patients undergoing surgery for HCC, and is able to classify such patients into three independent groups.
No takes yet. Share an insight, caveat, or question.
Ishizuka et al. (2011) conducted a cohort in Hepatocellular carcinoma (n=342). Underweight (BMI <22.5) vs. BMI ≥22.5 was evaluated on Postoperative death (OR 1.829, 95% CI 1.091-3.068, p=0.022). Being underweight (BMI <22.5) was a significant predictor of postoperative death in patients undergoing surgery for hepatocellular carcinoma (OR 1.829; 95% CI 1.091-3.068; P=0.022).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: